164 related articles for article (PubMed ID: 30669353)
1. Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability.
Khames A
Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30669353
[TBL] [Abstract][Full Text] [Related]
2. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
3. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique.
Khames A
Drug Deliv; 2017 Nov; 24(1):328-338. PubMed ID: 28165818
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity.
Abdallah MH; Abu Lila AS; El-Nahas HM; Ibrahim TM
Gels; 2023 Jun; 9(6):. PubMed ID: 37367164
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine Liquisolid Tablets Using Kolliphor EL with Improved Flowability and Bioavailability:
Korni RD; Gonugunta CSR
Turk J Pharm Sci; 2024 Mar; 21(1):52-61. PubMed ID: 38529549
[TBL] [Abstract][Full Text] [Related]
7. Self Nanoemulsifying Drug Delivery System of Sorafenib Tosylate: Development and
Sandhya P; Poornima P; Bhikshapathi DVRN
Pharm Nanotechnol; 2020; 8(6):471-484. PubMed ID: 33069205
[TBL] [Abstract][Full Text] [Related]
8. Improvement of dissolution profile of eplerenone with solidified self-emulsifying drug delivery systems (S-SEDDS).
Ranna R; Uner B; Ustundag Okur N; Tas C
Drug Dev Ind Pharm; 2023 Apr; 49(4):305-315. PubMed ID: 37133297
[TBL] [Abstract][Full Text] [Related]
9. Self-Nanoemulsifying Drug Delivery System of Coenzyme (Q10) with Improved Dissolution, Bioavailability, and Protective Efficiency on Liver Fibrosis.
Khattab A; Hassanin L; Zaki N
AAPS PharmSciTech; 2017 Jul; 18(5):1657-1672. PubMed ID: 27677262
[TBL] [Abstract][Full Text] [Related]
10. Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan-coated nanoemulsion.
Karami Z; Saghatchi Zanjani MR; Nasihatsheno N; Hamidi M
J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):717-728. PubMed ID: 31187938
[TBL] [Abstract][Full Text] [Related]
11. Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization,
Ahmed B; Rizwanullah M; Mir SR; Akhtar MS; Amin S
Biomed Mater; 2022 Sep; 17(6):. PubMed ID: 36108625
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation.
Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ
Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143
[TBL] [Abstract][Full Text] [Related]
13. The Effect of High-Pressure Homogenization Conditions on the Physicochemical Properties and Stability of Designed Fluconazole-Loaded Ocular Nanoemulsions.
Gawin-Mikołajewicz A; Nawrot U; Malec KH; Krajewska K; Nartowski KP; Karolewicz BL
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38276489
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Oral Bioavailability of Epalrestat SBE
Alvi Z; Akhtar M; Mahmood A; Ur-Rahman N; Nazir I; Sadaquat H; Ijaz M; Syed SK; Waqas MK; Wang Y
Int J Nanomedicine; 2021; 16():8353-8373. PubMed ID: 35002232
[TBL] [Abstract][Full Text] [Related]
15. Preparation and optimization of nilotinib self-micro-emulsifying drug delivery systems to enhance oral bioavailability.
Zakkula A; Gabani BB; Jairam RK; Kiran V; Todmal U; Mullangi R
Drug Dev Ind Pharm; 2020 Mar; 46(3):498-504. PubMed ID: 32067499
[No Abstract] [Full Text] [Related]
16. Design and development of letrozole nanoemulsion: A comparative evaluation of brain targeted nanoemulsion with free letrozole against status epilepticus and neurodegeneration in mice.
Iqbal R; Ahmed S; Jain GK; Vohora D
Int J Pharm; 2019 Jun; 565():20-32. PubMed ID: 31051232
[TBL] [Abstract][Full Text] [Related]
17. Rapid oral transmucosal delivery of zaleplon-lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation.
Ali SA; Alhakamy NA; Hosny KM; Alfayez E; Bukhary DM; Safhi AY; Badr MY; Mushtaq RY; Alharbi M; Huwaimel B; Alissa M; Alshehri S; Alamri AH; Alqahtani T
Drug Deliv; 2022 Dec; 29(1):2773-2783. PubMed ID: 36036168
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a curcumin nanoemulsion gel for the effective treatment of mycoses.
Al Fatease A; Alqahtani A; Khan BA; Mohamed JMM; Farhana SA
Sci Rep; 2023 Dec; 13(1):22730. PubMed ID: 38123572
[TBL] [Abstract][Full Text] [Related]
19. Impact of ultrasonication techniques on the preparation of novel Amiloride-nanoemulsion used for intranasal delivery in the treatment of epilepsy.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S192-S207. PubMed ID: 30032652
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of human oral bioavailability and in vitro antitumor activity of rosuvastatin via spray dried self-nanoemulsifying drug delivery system.
Kamel AO; Mahmoud AA
J Biomed Nanotechnol; 2013 Jan; 9(1):26-39. PubMed ID: 23627065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
